(Q35582820)

9 August 2017

1 reference

title

The epidemiology of gastroesophageal reflux disease (English)

1 reference

9 August 2017

The Epidemiology of Gastroesophageal Reflux Disease (English)

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

gastroesophageal reflux disease

1 April 2024

main subject

0 references

1 reference

1

Nicholas Shaheen

1 reference

9 August 2017

2

Dawn Provenzale

1 reference

9 August 2017

Nicholas Shaheen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14615667

1 April 2024

language of work or name

English

0 references

publication date

1 November 2003

1 reference

full work available at URL

9 August 2017

https://api.elsevier.com/content/article/PII:S0002962915341793?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

https://api.elsevier.com/content/article/PII:S0002962915341793?httpAccept=text/plain

1 April 2024

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

American Journal of the Medical Sciences

1 April 2024

published in

1 reference

9 August 2017

326

1 reference

9 August 2017

5

1 reference

9 August 2017

264-273

1 reference

Prevalence, severity and associated features of gastro-oesophageal reflux and dyspepsia: a population-based study

9 August 2017

1

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease

1 April 2024

2

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

The predictive value of symptoms in gastro-oesophageal reflux disease

1 April 2024

3

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. The Practice Parameters Committee of the American College of Gastroenterology

1 April 2024

4

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Symptomatic gastroesophageal reflux: incidence and precipitating factors

1 April 2024

6

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota.

1 April 2024

7

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

The prevalence of symptoms suggestive of esophageal disorders

1 April 2024

8

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Heartburn in Belgium: prevalence, impact on daily life, and utilization of medical resources

1 April 2024

10

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Prevalence and impact of symptoms suggestive of gastroesophageal reflux disease.

1 April 2024

11

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Upper gastrointestinal symptoms in North America: prevalence and relationship to healthcare utilization and quality of life

1 April 2024

12

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Dyspepsia in England and Scotland

1 April 2024

13

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Prevalence of symptoms suggestive of gastro-oesophageal reflux disease in an adult population.

1 April 2024

14

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

The prevalence of gastro-oesophageal reflux symptoms in a UK population and the consultation behaviour of patients with these symptoms

1 April 2024

15

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Prevalence of gastrointestinal symptoms in a multiracial Asian population, with particular reference to reflux-type symptoms

1 April 2024

17

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

The gastro-oesophageal reflux disease complex in sub-Saharan Africa

1 April 2024

19

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Upper gastrointestinal endoscopy in normal asymptomatic volunteers

1 April 2024

20

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Normal patterns of acid exposure at the gastric cardia: a functional midpoint between the esophagus and stomach

1 April 2024

21

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Ambulatory 24-hour esophageal pH monitoring. Reproducibility and variability of pH parameters

1 April 2024

22

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Objective determination of pH thresholds in the analysis of 24 h ambulatory oesophageal pH monitoring

1 April 2024

23

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Frequency and site of gastroesophageal reflux in patients with chest symptoms. Studies using proximal and distal pH monitoring

1 April 2024

24

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Opposing time trends of peptic ulcer and reflux disease

1 April 2024

26

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Epidemiology of reflux disease and reflux esophagitis.

1 April 2024

27

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Prevalence of gastroesophageal reflux in elderly patients in a primary care setting

1 April 2024

28

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Associations between different forms of gastro-oesophageal reflux disease

1 April 2024

29

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Obesity correlates with gastroesophageal reflux

1 April 2024

31

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Overweight, but not high dietary fat intake, increases risk of gastroesophageal reflux disease hospitalization: the NHANES I Epidemiologic Followup Study. First National Health and Nutrition Examination Survey

1 April 2024

33

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Risk factors associated with symptoms of gastroesophageal reflux

1 April 2024

34

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Three- to 4.5-year prospective study of prognostic indicators in gastro-oesophageal reflux disease.

1 April 2024

35

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Does massive obesity promote abnormal gastroesophageal reflux?

1 April 2024

36

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

No relation between body mass and gastro-oesophageal reflux symptoms in a Swedish population based study

1 April 2024

37

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Symptomatic improvement in gastroesophageal reflux disease (GERD) following laparoscopic Roux-en-Y gastric bypass.

1 April 2024

38

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Symptomatic and clinical improvement in morbidly obese patients with gastroesophageal reflux disease following Roux-en-Y gastric bypass

1 April 2024

39

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Gastroesophageal reflux in obese patients is not reduced by weight reduction

1 April 2024

40

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Body mass and reflux oesophagitis: an oestrogen-dependent association?

1 April 2024

41

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Relationship of hiatus hernia to reflux oesophagitis. A prospective study of coincidence, using endoscopy

1 April 2024

42

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Relationship between endoscopic hiatus hernia and gastroesophageal reflux symptoms

1 April 2024

43

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Hiatal hernia size is the dominant determinant of esophagitis presence and severity in gastroesophageal reflux disease

1 April 2024

44

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Hiatal hernia and acid reflux frequency predict presence and length of Barrett's esophagus

1 April 2024

45

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1,128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms

1 April 2024

46

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Clinical characteristics and natural history of patients with low-grade reflux esophagitis

1 April 2024

47

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data

1 April 2024

48

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Barrett's esophagus: clinical characteristics

1 April 2024

49

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma

1 April 2024

50

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Familial aggregation of gastroesophageal reflux in patients with Barrett's esophagus and esophageal adenocarcinoma

1 April 2024

51

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Gastroesophageal reflux disease in monozygotic and dizygotic twins

1 April 2024

52

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Familial aggregation of Barrett's oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults

1 April 2024

53

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Oesophagitis, signs of reflux, and gastric acid secretion in patients with symptoms of gastro-oesophageal reflux disease

1 April 2024

54

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Endoscopic evaluation of gastro-esophageal reflux disease

1 April 2024

55

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response

1 April 2024

56

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

High-dose proton-pump inhibitors as a diagnostic test of gastro-oesophageal reflux disease in endoscopic-negative patients

1 April 2024

57

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 months

1 April 2024

58

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Reflux symptom relief with omeprazole in patients without unequivocal oesophagitis

1 April 2024

59

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Natural history of gastro-oesophageal reflux disease without oesophagitis

1 April 2024

60

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Clinical characteristics and natural history of symptomatic but not excess gastroesophageal reflux

1 April 2024

61

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Different prevalences of reflux oesophagitis and hiatus hernia among dyspeptic patients in England and Singapore.

1 April 2024

63

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Healing and relapse of reflux esophagitis during treatment with ranitidine.

1 April 2024

64

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Erosive esophagitis and Barrett's esophagus in Taiwan: a higher frequency than expected

1 April 2024

65

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

The impact of upper GI endoscopy referral volume on the diagnosis of gastroesophageal reflux disease and its complications: a 1-year cross-sectional study in a referral area with 260,000 inhabitants

1 April 2024

66

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Diagnosis and management of peptic esophageal strictures

1 April 2024

67

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Hospital discharges resulting from esophagitis among medicare beneficiaries

1 April 2024

68

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

NSAIDs, aspirin, and esophageal strictures: are over-the-counter medications harmful to the esophagus?

1 April 2024

70

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review

1 April 2024

71

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Prevalence of Barrett's esophagus in asymptomatic individuals

1 April 2024

73

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus.

1 April 2024

74

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Upper endoscopy as a screening and surveillance tool in esophageal adenocarcinoma: a review of the evidence

1 April 2024

75

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Is there publication bias in the reporting of cancer risk in Barrett's esophagus?

1 April 2024

77

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Epidemiology of gastro-esophageal reflux disease

1 April 2024

82

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Prevalence of metaplasia at the gastro-oesophageal junction

1 April 2024

83

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Prevalence of Barrett's esophagus by endoscopy and histologic studies: a prospective evaluation of 306 control subjects and 376 patients with symptoms of gastroesophageal reflux

1 April 2024

84

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

The prevalence of Barrett's esophagus in patients with chronic peptic esophageal strictures

1 April 2024

86

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Risk factors for Barrett's esophagus in community-based practice. GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy

1 April 2024

87

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Complications of gastroesophageal reflux disease. Role of the lower esophageal sphincter, esophageal acid and acid/alkaline exposure, and duodenogastric reflux

1 April 2024

88

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease

1 April 2024

89

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

Barrett's esophagus: its prevalence and association with adenocarcinoma in patients with symptoms of gastroesophageal reflux

1 April 2024

90

1 reference

https://api.crossref.org/works/10.1097/00000441-200311000-00002

1 April 2024

Identifiers

1 reference

9 August 2017

1 reference